News & Updates

$Sequential therapy with abaloparatide, alendronate cuts fracture risk in older women$

Sequential therapy with abaloparatide, alendronate cuts fracture risk in older women

30 Jul 2020

A strategy of administering abaloparatide for 18 months followed by 24 months of alendronate holds fracture risk at bay in older postmenopausal women with osteoporosis, as shown in a study.

Sequential therapy with abaloparatide, alendronate cuts fracture risk in older women

30 Jul 2020

E. coli strains potential agents of colorectal cancer

30 Jul 2020 by

Certain Escherichia coli strains with carcinogenic potential are more prevalent in Malaysian patients with colorectal cancer (CRC) than healthy individuals, according to a new study.

E. coli strains potential agents of colorectal cancer

30 Jul 2020

Ad5-vectored COVID-19 vaccine gets a boost with phase 2 data

29 Jul 2020 by

Amidst the global race for a vaccine against COVID-19, the Ad5*-vectored COVID-19 (Ad5-nCoV) vaccine gets a boost with the release of encouraging data from the phase II trial, which provide further evidence supporting the safety and immunogenicity of this vaccine.

Ad5-vectored COVID-19 vaccine gets a boost with phase 2 data

29 Jul 2020

Skin prep type has no effect on SSI in gynae laparoscopy

29 Jul 2020 by

Type of pre-operative skin preparation solution – alcohol-based chlorhexidine or alcohol- or water-based povidone iodine – had no bearing on the risk of surgical site infection (SSI) in women undergoing gynaecological laparoscopy, according to a study conducted in Australia.

Skin prep type has no effect on SSI in gynae laparoscopy

29 Jul 2020

Some meds may be driving weight gain in postmenopausal women

29 Jul 2020

Use of antidepressants, beta-blockers, or insulin appears to contribute to increased weight in postmenopausal women, a study has found.

Some meds may be driving weight gain in postmenopausal women

29 Jul 2020

Adjunctive perampanel efficacy, safety in epilepsy hold up over long-term assessment

29 Jul 2020

Adjunctive perampanel appears to be safe and effective for long-term treatment of patients with tonic‐clonic seizures, according to a posthoc analysis.

Adjunctive perampanel efficacy, safety in epilepsy hold up over long-term assessment

29 Jul 2020

Musculoskeletal pain intensity, catastrophizing predict healthcare utilization, opioid use

28 Jul 2020

Pain intensity and catastrophizing both affect healthcare utilization and costs in patients with musculoskeletal injuries, a recent study has shown.

Musculoskeletal pain intensity, catastrophizing predict healthcare utilization, opioid use

28 Jul 2020

Sarilumab a fruitful approach to treating severe COVID-19 with hyperinflammation

28 Jul 2020

Interleukin-6 blockade with sarilumab shows potential in the treatment of severe COVID-19 pneumonia with systemic hyperinflammation, with patients showing overall clinical improvement and survival within roughly a month, according to the results of an open-label study.

Sarilumab a fruitful approach to treating severe COVID-19 with hyperinflammation

28 Jul 2020

EMPRISE reinforces CV benefits of empagliflozin

28 Jul 2020 by

The efficacy and cardiovascular (CV) safety of the SGLT2* inhibitor empagliflozin vs DPP-4** inhibitors and GLP-1*** receptor agonists in real-world patients were demonstrated in two interim analyses of the EMPRISE⁺ study presented at ADA 2020.

EMPRISE reinforces CV benefits of empagliflozin

28 Jul 2020

COVID-19 patients harbour SARS-CoV-2 T cells

28 Jul 2020 by

Patients who recovered from COVID-19 harbour SARS-CoV-2-specific T cells as shown in a Singapore study. This, the scientists suggest, bodes well for the development of long-term protective immunity against the coronavirus.

COVID-19 patients harbour SARS-CoV-2 T cells

28 Jul 2020

News & Updates

Filter by Specialty:

Specialty:

Sequential therapy with abaloparatide, alendronate cuts fracture risk in older women

Sequential therapy with abaloparatide, alendronate cuts fracture risk in older women

E. coli strains potential agents of colorectal cancer

E. coli strains potential agents of colorectal cancer

Ad5-vectored COVID-19 vaccine gets a boost with phase 2 data

Ad5-vectored COVID-19 vaccine gets a boost with phase 2 data

Skin prep type has no effect on SSI in gynae laparoscopy

Skin prep type has no effect on SSI in gynae laparoscopy

Some meds may be driving weight gain in postmenopausal women

Some meds may be driving weight gain in postmenopausal women

Adjunctive perampanel efficacy, safety in epilepsy hold up over long-term assessment

Adjunctive perampanel efficacy, safety in epilepsy hold up over long-term assessment

Musculoskeletal pain intensity, catastrophizing predict healthcare utilization, opioid use

Musculoskeletal pain intensity, catastrophizing predict healthcare utilization, opioid use

Sarilumab a fruitful approach to treating severe COVID-19 with hyperinflammation

Sarilumab a fruitful approach to treating severe COVID-19 with hyperinflammation

EMPRISE reinforces CV benefits of empagliflozin

EMPRISE reinforces CV benefits of empagliflozin

COVID-19 patients harbour SARS-CoV-2 T cells

COVID-19 patients harbour SARS-CoV-2 T cells